Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review

Sebastian Franik; Jan A M Kremer; Willianne L D M Nelen; Cynthia Farquhar; Jane Marjoribanks

doi:10.1016/j.fertnstert.2014.10.016

Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review

Fertil Steril. 2015 Feb;103(2):353-5. doi: 10.1016/j.fertnstert.2014.10.016. Epub 2014 Nov 5.

Authors

Sebastian Franik¹, Jan A M Kremer², Willianne L D M Nelen², Cynthia Farquhar³, Jane Marjoribanks⁴

Affiliations

¹ Faculty of Medical School, Radboud University Medical Center, Nijmegen, the Netherlands.
² Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands.
³ Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
⁴ Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand. Electronic address: [email protected].

PMID: 25455536
DOI: 10.1016/j.fertnstert.2014.10.016

Abstract

Polycystic ovary syndrome (PCOS) is a common cause of anovulatory subfertility. We evaluated the effectiveness and safety of aromatase inhibitors compared with other methods of ovulation induction in women with anovulatory PCOS.

Keywords: Aromatase inhibitors; infertility; letrozole; ovulation induction; polycystic ovary syndrome.

Publication types

Review

MeSH terms

Aromatase Inhibitors / therapeutic use*
Female
Humans
Infertility, Female / diagnosis
Infertility, Female / drug therapy*
Infertility, Female / epidemiology
Ovulation Induction / methods*
Polycystic Ovary Syndrome / diagnosis
Polycystic Ovary Syndrome / drug therapy*
Polycystic Ovary Syndrome / epidemiology
Randomized Controlled Trials as Topic / methods

Substances

Aromatase Inhibitors